J-Pharma Co (TSE:520A) EPS (Diluted): 円 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円290.00
View Full Analysis

What is J-Pharma Co EPS (Diluted)?

J-Pharma Co TSE:520A -2.36% 9 EPS (Diluted) is 円 as of Dec. 2025. GuruFocus rates TSE:520A with a GF Score™ of 9/100.

J-Pharma Co's Earnings per Share (Diluted) for the three months ended in Dec. 2025 was 円-25.12.

J-Pharma Co's EPS (Basic) for the three months ended in Dec. 2025 was 円-25.12.

J-Pharma Co's EPS without NRI for the three months ended in Dec. 2025 was 円-25.29.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

J-Pharma Co  (TSE:520A) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

J-Pharma Co EPS (Diluted) Related Terms

J-Pharma Co EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co EPS (Diluted) Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
EPS (Diluted)
-92.67 -84.07

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
EPS (Diluted) 0.00 0.00 -25.12

TSE:520A vs VRTX, REGN, ALNY: EPS (Diluted) Comparison

For the Biotechnology subindustry, J-Pharma Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

J-Pharma Co PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, J-Pharma Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where J-Pharma Co's PE Ratio falls into.


TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J-Pharma Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

J-Pharma Co's Diluted EPS for the fiscal year that ended in Mar. 2025 is calculated as

Diluted EPS (A: Mar. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1499.008-0)/17.830
=-84.07

J-Pharma Co's Diluted EPS for the quarter that ended in Dec. 2025 is calculated as

Diluted EPS (Q: Dec. 2025 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-447.927-0)/17.830
=-25.12

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of 円 mean?
J-Pharma Co (TSE:520A) has a EPS (Diluted) of 円 as of Dec. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on J-Pharma Co and its competitors.
Is J-Pharma Co's EPS (Diluted) too high?
J-Pharma Co's current EPS (Diluted) is 円. Overall, J-Pharma Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does J-Pharma Co's EPS (Diluted) compare to VRTX and REGN?
J-Pharma Co's EPS (Diluted) of 円 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Biotechnology company?
A good EPS (Diluted) depends on the Biotechnology industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on J-Pharma Co and its competitors. J-Pharma Co's current EPS (Diluted) is 円. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J-Pharma Co stock overvalued right now?
J-Pharma Co (TSE:520A) has a current EPS (Diluted) of 円. The current EPS (Diluted) is 円. J-Pharma Co's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For J-Pharma Co (TSE:520A), the current EPS (Diluted) is 円 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円290.00
Price